Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this exploratory randomized controlled clinical study is to evaluate the health-promoting effects of Kneipp hydrotherapy, in the form of the Vital Shower in a four-week daily application.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Vital shower | Active Comparator | Participants receive a prototype/shower head from Hansgrohe and training including a handout. After installation, participants are asked to shower daily for four weeks according to a predefined shower protocol. |
|
| Regular shower | No Intervention | Participants are advised not to change their showering behaviour; at the end of the study, the participants receive an offer of a shower head for free. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Hansgrohe prototype/shower head | Device | Start of the shower with warm comfort temperature and usual body cleansing. Then the Vital shower is carried out for a total of 3-5 minutes, followed optionally by another warm shower with 30 seconds or direct transition to a classic cold shower for 30- 60 seconds |
| Measure | Description | Time Frame |
|---|---|---|
| Immunological laboratory | T-Cells (CD3), B-Cells (CD19), Natural Killer Cells (CD16), T-helper cells (CD4), cytotoxic T-cells (CD8), CD4/CD8 ratio, interleukin 4, interferon gamma | Change from Baseline and after 4 weeks |
| Blood pressure at rest (systolic and diastolic) | Change from Baseline and after 4 weeks | |
| Hospital Anxiety and Depression Scale (HADS-D) | Change | Change from HADS-D Baseline, after 4 weeks and 12 weeks |
| Self-Efficacy Scale (ASKU) | Change | Change from ASKU Baseline, after 4 weeks and 12 weeks |
| WHO-Five Well-Being Index (WHO-5) | Change | Change from WHO-5 Baseline, after 4 weeks and 12 weeks |
| Perceived Stress Scale (PSS-10) | Change | Change from PSS-10 Baseline, after 4 weeks and 12 weeks |
| Flourishing Scale (FS-D) | Change | Change from FS-D Baseline, after 4 weeks and 12 weeks |
| Insomnia Severity Index (ISI-D) | Change | Change from ISI-D Baseline, after 4 weeks and 12 weeks |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Miriam Rösner | Contact | 03080505682 | miriam.roesner@immanuelalbertinen.de |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Charité Hochschulambulanz für Naturheilkunde am Immanuel Krankenhaus | Recruiting | Berlin | State of Berlin | 14163 | Germany |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Short Form (SF-36) | Change | Change from SF-36 Baseline, after 4 weeks and 12 weeks |
| Von Zerssen somatic complaint list (B-LR and B-LR') | Change | Change from B-LR and B-LR' Baseline, after 4 weeks and 12 weeks |
| Heart rate variability | Change | Change from Baseline and after 4 weeks |